Llwytho...
Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1
OBJECTIVE: Celastrol was recently identified as a potential novel treatment for obesity. However, the effect of Celastrol on nonalcoholic fatty liver disease (NAFLD) remains elusive. The aim of this study is to evaluate the role of Celastrol in NAFLD. METHODS: Functional studies were performed using...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Mol Metab |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5220393/ https://ncbi.nlm.nih.gov/pubmed/28123944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2016.11.002 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|